Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials

Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials

Background: As immune checkpoint inhibitors (ICIs) transition to the forefront of cancer treatment, a better understanding of immune related adverse events (IRAEs) is essential to promote safe clinical practice. Dermatologic adverse events are the most common IRAEs and can lead to drug withdrawal an...

Full description

Bibliographic Details
Main Authors: Yang Ge, Huiyun Zhang, Nathaniel Weygant, Jiannan Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Pharmacology
Subjects:
meta-analysis
checkpoint inhibitors
combination immunotherapy
immune-related adverse events
dermatologic adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.640099/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.640099/full

Similar Items